Shilpa Medicare Share Price

Shilpa Medicare Share Price

NSE: SHILPAMED
|
Pharmaceuticals
|
S Cap
₹ 815.00
+₹7.95 (0.99%)
1D
Last updated 14 Aug, 2026, 09:58 IST

Shilpa Medicare Share Price Today

As of 14 Aug 2026, Shilpa Medicare share price is ₹815.00. The stock opened at ₹811.60, compared to its previous close of ₹807.05. During today's trading session, Shilpa Medicare share price moved in the range of ₹810.05 to ₹825.00, with an average price of ₹817.52 for the day. Looking at its last 52-week, the stock has touched a low of ₹259.50 and a high of ₹825.40. On the performance front, Shilpa Medicare share price has increased by 146.96% over the last six months and is up 78.12% on a year-on-year basis.

₹810.05
0.99% up today
₹825.00
1D LOW
1D HIGH

Shilpa Medicare Returns Calculator

Circuit
L
H
₹645.65
₹968.45
52-week
L
H
₹259.50
₹825.40

About Shilpa Medicare

Shilpa Medicare Share Price
ISIN
INE790G01031
Sector Market Cap
₹ 15,791.3 Cr

Shilpa Medicare Limited is an India-based pharmaceutical company. The Company is engaged in the manufacturing of active pharmaceutical ingredients (APIs), formulation and development service. It is engaged in APIs, intermediates, formulations, new drug delivery systems, peptides / biotech products and specialty chemicals, and others. The Company supplies more than 30 oncology APIs including key products such as Capecitabine, Gemcitabine Hydrochloride, Pemetrexed, Axitinib, Erlotinib Hydrochloride and Irinotecan Hydrochloride for various international markets including United States of America, Europe, Japan, South Korea, Russia, Mexico, Brazil, and other emerging markets. Its non-Oncology API products include Ambroxol (Mucolytic agent), Tranexmic Acid and Ursodeoxycholic Acid. Its Injectable Dosage Forms include Myelodysplastic Syndrome, Breast Cancer, Multiple Myeloma, and more. Its Oral Solid Dosage Forms include Psoriasis, Prostate Cancer, Multiple Sclerosis, and others.

Shilpa Medicare Financial Highlights

  • Revenue: Shilpa Medicare reported revenue of ₹1,548.71 crore in FY26 vs ₹1,309.76 crore in FY25. It showed an increase of 18.24% on a yearly basis.
  • Operating Profit: Shilpa Medicare reported an operating profit of ₹295.31 crore in FY26 vs ₹122.33 crore in FY25. It showed an increase of 141.40% on a year-on-year basis.
  • Net Profit: Shilpa Medicare reported a net profit of ₹243.33 crore in FY26 vs ₹78.29 crore in FY25. It showed an increase of 210.81% on a yearly basis.

Shilpa Medicare Quarterly Result Highlights

  • Shilpa Medicare reported revenue of ₹468.91 crore in Jun 2026, compared with ₹438.66 crore in Mar 2026, representing an increase of 6.90% on a quarter-on-quarter (QoQ) basis.
  • Shilpa Medicare reported an operating profit of ₹98.06 crore in Jun 2026, compared with ₹120.44 crore in Mar 2026, representing a decrease of 18.58% on a quarter-on-quarter (QoQ) basis.
  • Shilpa Medicare reported a profit of ₹100.88 crore in Jun 2026, compared with ₹107.79 crore in Mar 2026, reflecting a decrease of 6.41% on a QoQ basis.
  • The earnings per share (EPS) of Shilpa Medicare stood at ₹8.04 during Jun 2026.
Know more
Promoters
40.13%
FII
11.38%
Other DII
3.84%
Retail and other
40.43%
Mutual funds
4.21%
Foreign institutions - FII
FII shareholding by period
Sep 202510.92%
Dec 202510.97%
Mar 202611.08%
Jun 202611.38%
Mkt Cap Cr
15,791.30
P/E
53.12
P/B
6.09
ROE
9.39%
D/E
0.05
ROCE
10.73%
Div. Yield
0.07%
EPS(TTM)
6.80
Turnover
0.23
EV/EBITDA
31.35
Net Margin
0.00%
Op. Margin
0.00%
ROA
8.02%
Quick Ratio
0.00
Curr. Ratio
3.29
Based on fundamentals, this stock's
Step 5 of 5
Performance
Excellent
Shilpa Medicare outperforming all market indices
Step 1 of 5
Valuation
Overvalued
Shilpa Medicare appears overvalued compared to its peers
Step 4 of 5
Earnings
Good
Shilpa Medicare revenue, operating profit and net profit are growing
Peer Comparison
Peer comparison — key ratios
NameMkt Cap CrP/EP/BROED/EROCEBook ValueDiv. YieldTurnoverEPS(TTM)
Sun Pharmaceutical Industries4,66,155.0038.475.5813.74%0.6117.33%93.240.83%0.4810.90
Divis Laboratories2,26,843.0077.1513.4615.32%0.0019.56%629.490.35%0.5598.19
Torrent Pharmaceuticals1,86,000.0086.2722.1225.49%1.6913.85%222.760.69%0.4958.70
Zydus Lifesciences1,17,007.0026.154.4318.59%0.3117.35%237.300.08%0.3335.38
Cipla1,18,027.0035.173.4311.27%0.0014.95%423.360.89%0.4543.52
Lupin1,03,549.0018.624.6123.76%0.0424.88%659.050.79%0.57129.18
Mankind Pharma1,00,137.0048.436.1411.74%0.3413.13%397.020.04%0.4449.37
Dr. Reddy's Laboratories1,00,662.0031.622.6411.07%0.1812.54%377.960.67%0.4138.68
Laurus Labs99,474.2091.2318.7716.77%0.4016.14%97.200.11%0.6713.72
Aurobindo Pharma96,215.6026.062.559.25%0.1911.76%391.140.24%0.3841.58

Shilpa Medicare Financials

Full statement

Income Statement · Consolidated

Income Statement · Consolidated — all values in INR Crore
ParticularsMar 2025Mar 2024Mar 2023Mar 2022
Revenue₹1,286.41₹1,151.60₹1,050.11₹1,145.52
Other Income₹23.15₹8.17₹17.40₹14.25
Total Revenue₹1,309.57₹1,159.77₹1,067.51₹1,159.77
Total Expenses₹1,157.89₹1,106.79₹1,101.98₹1,062.63
Profit Before Tax₹122.33₹54.34-₹38.28₹102.26
Tax₹44.04₹22.39-₹7.31₹41.68
Profit After Tax₹78.30₹31.96-₹30.97₹60.58
EPS - Basic₹8.04₹3.67-₹3.75₹7.26
EPS - Diluted₹8.04₹3.67-₹3.75₹7.26

Cash Flow · Consolidated

Cash Flow · Consolidated — all values in INR Crore
ParticularsMar 2025Mar 2024Mar 2023Mar 2022
Profit before tax₹122.33₹54.34-₹38.28₹102.26
Income before WC changes₹317.38₹275.78₹109.53₹211.61
Change in Assets-₹122.76-₹125.72₹107.29-₹186.98
Change in Liabilities-₹15.41₹27.80-₹4.52₹114.99
Change in WC-₹138.18-₹97.92₹102.77-₹71.99
Cash flow from Operations₹132.18₹136.67₹179.92₹105.13
Cash flow from Investing-₹199.08-₹166.58-₹232.61-₹285.50
Cash flow from Financing₹62.65₹46.78₹45.80₹82.86
Total Cash Flow-₹4.25₹16.86-₹6.89-₹97.51
Cash (Start of the year)₹31.76₹19.07₹25.62₹122.85
Cash (End of the year)₹28.52₹31.76₹19.07₹25.34

Balance Sheet · Consolidated

Balance Sheet · Consolidated — all values in INR Crore
ParticularsMar 2025Mar 2024Mar 2023Mar 2022
Non-Current Assets₹2,325.04₹2,216.38₹2,134.37₹1,988.30
Current Assets₹985.67₹876.83₹769.55₹887.19
Total Assets₹3,310.71₹3,093.20₹2,903.93₹2,875.50
Current Liabilities₹674.23₹693.35₹784.45₹611.54
Net Current Asset₹311.44₹183.48-₹14.89₹275.66
Non-Current Liabilities₹272.77₹599.90₹345.12₹452.82
Equity Capital₹2,363.70₹1,799.96₹1,774.36₹1,811.15
Total Equity & Liabilities₹3,310.71₹3,093.20₹2,903.93₹2,875.50

Income Statement · Standalone

Income Statement · Standalone — all values in INR Crore
ParticularsMar 2025Mar 2024Mar 2023Mar 2022
Revenue₹477.34₹309.79₹247.70₹356.95
Other Income₹83.83₹89.12₹68.64₹40.86
Total Revenue₹561.18₹398.90₹316.35₹397.81
Total Expenses₹408.20₹350.36₹359.08₹379.14
Profit Before Tax₹107.24₹38.09-₹58.28₹27.49
Tax₹37.43₹11.15-₹8.79₹7.33
Profit After Tax₹69.80₹26.94-₹49.48₹20.16
EPS - Basic₹7.16₹3.10₹6.59₹16.87
EPS - Diluted₹7.16₹3.10₹6.59₹16.87

Cash Flow · Standalone

Cash Flow · Standalone — all values in INR Crore
ParticularsMar 2025Mar 2024Mar 2023Mar 2022
Profit before tax₹107.24₹38.09₹12.68₹192.89
Income before WC changes₹114.49₹55.22-₹22.88₹225.53
Change in Assets-₹148.47-₹64.71₹21.21-₹113.72
Change in Liabilities₹32.29₹25.99₹12.16₹96.55
Change in WC-₹116.18-₹38.72₹33.37-₹17.17
Cash flow from Operations-₹19.06₹9.55₹2.08₹173.87
Cash flow from Investing-₹433.29₹155.82-₹94.83-₹378.97
Cash flow from Financing₹450.09-₹163.07₹87.68₹97.23
Total Cash Flow-₹2.26₹2.30-₹5.07-₹107.88
Cash (Start of the year)₹4.46₹2.49₹7.42₹115.01
Cash (End of the year)₹4.42₹4.46₹2.35₹7.13

Balance Sheet · Standalone

Balance Sheet · Standalone — all values in INR Crore
ParticularsMar 2025Mar 2024Mar 2023Mar 2022
Non-Current Assets₹2,529.38₹2,041.66₹1,882.41₹2,586.68
Current Assets₹477.29₹376.97₹636.25₹309.44
Total Assets₹3,006.66₹2,418.62₹2,518.66₹2,896.12
Current Liabilities₹226.89₹212.64₹242.71₹161.65
Net Current Asset₹250.40₹164.33₹393.54₹147.79
Non-Current Liabilities₹79.18₹63.27₹158.37₹668.80
Equity Capital₹2,700.59₹2,142.72₹2,117.58₹2,065.67
Total Equity & Liabilities₹3,006.66₹2,418.62₹2,518.66₹2,896.12
* All values are in INR Crore
Qty
Bid
1071
814.5
119
814.45
136
814.4
41
814.3
1
814.15
Ask
Qty
815
445
815.05
2
815.15
24
815.2
98
815.25
36
Bid Total: 1368
Ask Total: 605
Buy orders: 69%
Sell orders: 31%
Bearish
4
Neutral
2
Bullish
2
Slightly Bearish
by SEBI experts
Expert Pick
EXPPICK
Stop-loss
Entry price
Target
Indicator
Value
Verdict
RSI (14)
79.01
Bullish
ATR (14)
36.37
Neutral
STOCH(9,6)
91.32
Bearish
STOCH RSI (14)
85.91
Bearish
ADX(9)
57.6
Bearish
UO(9)
61.89
Neutral
ROC(12)
33.35
Bullish
WillR(14)
-8.14
Bearish
Period
Simple value
Exponential vaue
5D
799.85
789.24
10D
733.93
749.21
20D
674.07
699.92
50D
617.36
624.34
100D
520.23
547.09
Volume trend — traded volume by day
14 Aug3L
13 Aug13L
12 Aug9L
11 Aug24L
10 Aug63L
7 Aug63L
Average29L
Compare against other stocks
Shilpa Medicare Share Price
Shilpa Medicare
Pharmaceuticals
Add Stock
Add Another

Shilpa Medicare Share Price FAQs